GlassScriptPhysician profile
Sylvia Y Lam
NPI 1205884442
$503.88
in general payments reported to CMS, 2019-2025
7 companies · $61.95 in 2025
The $61.95 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $62.89 · 2021: $24.71 · 2023: $29.34 · 2024: $325 · 2025: $61.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $154.45 | 2023-2025 | Bexsero |
| Regeneron Healthcare Solutions, INC. | $130.02 | 2020-2024 | Dupixent |
| Genzyme Corporation | $57.24 | 2020-2024 | |
| Medtronic, INC. | $52.19 | 2024 | Intellis Adaptivestim |
| Merck Sharp & Dohme LLC | $50.13 | 2021-2025 | Vaxneuvance, Rotateq, Vaxelis |
| Alk-Abello, INC | $33.25 | 2023-2025 | Neffy, Odactra, Ragwitek |
| Takeda Pharmaceuticals U.S.A., INC. | $26.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sylvia Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.